Press releases
- Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A
- Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio
- Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
- Sobi publishes Annual and sustainability report for 2023
- Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024
More ▼
Key statistics
On Friday, Swedish Orphan Biovitrum AB (publ) (BVT:DEU) closed at 23.96, -8.13% below its 52-week high of 26.08, set on Jan 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 23.88 |
---|---|
High | 24.22 |
Low | 23.86 |
Bid | 24.00 |
Offer | 24.24 |
Previous close | 23.84 |
Average volume | 152.30 |
---|---|
Shares outstanding | 354.36m |
Free float | 195.56m |
P/E (TTM) | 45.24 |
Market cap | 99.22bn SEK |
EPS (TTM) | 6.19 SEK |
Data delayed at least 15 minutes, as of May 03 2024.
More ▼